Canada
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.49 B
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
2 |
USD 548.06 M
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
3 |
USD 77.77 M
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
4 |
USD 8.89 M
|
Sept. 30, 2023 | USD 1.91 | 1.06% |
|
Canada |
|
5 |
USD 8.87 M
|
Aug. 31, 2024 | USD 1.86 | 5.08% |
|
Canada |
|
6 |
USD 5.47 M
|
Dec. 31, 2023 | USD 0.89 | -2.92% |
|
Canada |
The Vaccines company in Canada with the highest Total Assets is AbCellera Biologics Inc. (NasdaqGS: ABCL) at USD 1.49 B.
The Vaccines company in Canada with the lowest Total Assets is XORTX Therapeutics Inc. (TSXV: XRTX.V) at USD 5.47 M.
The top 10 Vaccines companies in Canada by Total Assets are AbCellera Biologics Inc., Aurinia Pharmaceuticals Inc., Theratechnologies Inc., Edesa Biotech, Inc., Lexaria Bioscience Corp. and XORTX Therapeutics Inc..
The bottom 10 Vaccines companies in Canada by Total Assets are XORTX Therapeutics Inc., Lexaria Bioscience Corp., Edesa Biotech, Inc., Theratechnologies Inc., Aurinia Pharmaceuticals Inc. and AbCellera Biologics Inc..